Last updated on August 2018

Unilateral Meniere's Disease

Brief description of study

A prospective, randomized, double blind, placebo-controlled, multi-center, phase 3 efficacy and safety study of OTO-104 given as a single intratympanic injection in subjects with unilateral Meniere's disease.


Clinical Study Identifier: TX210450

Contact Investigators or Research Sites near you

Start Over

Lindy Carter

Piedmont Ear, Nose, and Throat Associates
Winston-Salem, NC USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.